Literature DB >> 21643793

An improved approach to steady-state analysis of monoamine oxidases.

Rona R Ramsay1, Aldo Olivieri, Andrew Holt.   

Abstract

The search for new monoamine oxidase inhibitors aims to identify potential lead compounds that are more potent and selective than current drugs for use in treating a variety of neuropsychiatric and neurodegenerative conditions. An integral part of this process is a kinetic examination of monoamine oxidases in the presence of the inhibitor, to determine potency and selectivity and to obtain information on mechanism. To date, kinetic data obtained with a probe substrate have been analysed by fitting to the Michaelis-Menten equation which describes a unireactant process in which velocity is related to substrate concentration in a rectangular hyperbolic manner. In this study, we present evidence that monoamine oxidase activity is often not adequately described by this approach. We outline a novel equation strategy that takes account of substrate and inhibitor binding to oxidised and reduced enzyme forms, and quantifies differences between substrates and inhibitors in this regard. When combined with plate reader-based experimental techniques that allow large numbers of substrate and inhibitor concentrations to be used, and the global nonlinear regression facilities of GraphPad Prism software, this straightforward approach allows more appropriate analyses of monoamine oxidase by non-experts than has previously been possible.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643793     DOI: 10.1007/s00702-011-0657-y

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  27 in total

Review 1.  The therapeutic potential of monoamine oxidase inhibitors.

Authors:  Moussa B H Youdim; Dale Edmondson; Keith F Tipton
Journal:  Nat Rev Neurosci       Date:  2006-04       Impact factor: 34.870

2.  Structure-activity relations in the oxidation of phenethylamine analogues by recombinant human liver monoamine oxidase A.

Authors:  R K Nandigama; D E Edmondson
Journal:  Biochemistry       Date:  2000-12-12       Impact factor: 3.162

3.  Interactions of tricyclic antidepressant drugs with human and rat monoamine oxidase type B.

Authors:  A A Reid; J L Hill; D L Murphy
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

4.  Kinetic studies on the catalytic mechanism of liver monoamine oxidase.

Authors:  M Husain; D E Edmondson; T P Singer
Journal:  Biochemistry       Date:  1982-02-02       Impact factor: 3.162

5.  Potentiation of ligand binding through cooperative effects in monoamine oxidase B.

Authors:  Daniele Bonivento; Erika M Milczek; G Reid McDonald; Claudia Binda; Andrew Holt; Dale E Edmondson; Andrea Mattevi
Journal:  J Biol Chem       Date:  2010-09-20       Impact factor: 5.157

6.  Multiple binding sites for substrates and modulators of semicarbazide-sensitive amine oxidases: kinetic consequences.

Authors:  Andrew Holt; David J Smith; Laura Cendron; Giuseppe Zanotti; Adelio Rigo; Maria Luisa Di Paolo
Journal:  Mol Pharmacol       Date:  2007-11-07       Impact factor: 4.436

7.  Evidence for a single catalytic binding site on human brain type B monoamine oxidase.

Authors:  J A Roth
Journal:  J Neurochem       Date:  1976-11       Impact factor: 5.372

8.  Interactions of imidazoline ligands with the active site of purified monoamine oxidase A.

Authors:  Tadeusz Z E Jones; Laura Giurato; Salvatore Guccione; Rona R Ramsay
Journal:  FEBS J       Date:  2007-03       Impact factor: 5.542

9.  Steady-state kinetic studies on benzylamine oxidase from pig plasma.

Authors:  I D Kelly; P F Knowles; K D Yadav; W G Bardsley; P Leff; R D Waight
Journal:  Eur J Biochem       Date:  1981

10.  Multiple pathways guide oxygen diffusion into flavoenzyme active sites.

Authors:  Riccardo Baron; Conor Riley; Pirom Chenprakhon; Kittisak Thotsaporn; Remko T Winter; Andrea Alfieri; Federico Forneris; Willem J H van Berkel; Pimchai Chaiyen; Marco W Fraaije; Andrea Mattevi; J Andrew McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-06-16       Impact factor: 11.205

View more
  7 in total

Review 1.  On the practical aspects of characterising monoamine oxidase inhibition in vitro.

Authors:  Andrew Holt
Journal:  J Neural Transm (Vienna)       Date:  2018-10-29       Impact factor: 3.575

2.  Targeting imidazoline site on monoamine oxidase B through molecular docking simulations.

Authors:  Fernanda Pretto Moraes; Walter Filgueira de Azevedo
Journal:  J Mol Model       Date:  2012-03-17       Impact factor: 1.810

3.  Quantum-chemical approach to determining the high potency of clorgyline as an irreversible acetylenic monoamine oxidase inhibitor.

Authors:  Matic Pavlin; Janez Mavri; Matej Repič; Robert Vianello
Journal:  J Neural Transm (Vienna)       Date:  2013-04-02       Impact factor: 3.575

Review 4.  Kinetics, mechanism, and inhibition of monoamine oxidase.

Authors:  Rona R Ramsay; Alen Albreht
Journal:  J Neural Transm (Vienna)       Date:  2018-03-07       Impact factor: 3.575

5.  Radiochemical Assay of Monoamine Oxidase Activity.

Authors:  Andrew Holt
Journal:  Methods Mol Biol       Date:  2023

Review 6.  Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration.

Authors:  Rona R Ramsay; Magdalena Majekova; Milagros Medina; Massimo Valoti
Journal:  Front Neurosci       Date:  2016-08-22       Impact factor: 4.677

Review 7.  Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs.

Authors:  Rona R Ramsay; Keith F Tipton
Journal:  Molecules       Date:  2017-07-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.